The results nevertheless make Opdualag an alternative to Opdivo plus Yervoy (ipilimumab) – BMS' notoriously hard to tolerate CTLA4 checkpoint inhibitor – which has been approved as a ...
Rory Steen, Denver, CO: “I don’t know about you guys, but I’m one Guinness away from believing I’m a prince.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback